KURISCHKO ANATOLI
No ORCID on file
· 18 papers in corpus
· active 1998
Frequent coauthors
- BERTRAM GUDRUN 18
- KASCH HELMUT 18
- MENZENBACH BERND 18
- PONSOLD KURT 18
- ROHRIG HEIDEMARIE 18
- SCHUBERT GERD 18
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …
1998
The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and …